First test of 'Ready-Made' cell therapy for tough lymphomas
Disease control
Completed
This early-stage study tested the safety and initial effectiveness of a new type of cell therapy called ALLO-501 in adults with lymphoma that has come back or not responded to prior treatments. Unlike most CAR T-cell therapies made from a patient's own cells, this one is made fro…
Phase: PHASE1 • Sponsor: Allogene Therapeutics • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC